epilepsiaEpilepsy and paroxysmal conditionsЭпилепсия и пароксизмальные состояния2077-83332311-4088IRBIS LLCepilepsia-6Research ArticleCLINICAL LECTURESКЛИНИЧЕСКИЕ ЛЕКЦИИПСИХОНЕВРОЛОГИЧЕСКИЕ ЭФФЕКТЫ ЭСЛИКАРБАЗЕПИНА АЦЕТАТАБурдС. Г.
Бурд Сергей Георгиевич ― доктор медицинских наук профессор кафедры нервных болезней лечебного факультета
Российский национальный исследовательский медицинский университет им. Н.И. Пирогова, МоскваRussian Federation20152905201670Special issue1317Copyright © Бурд С.Г., 20162016Бурд С.Г.Бурд С.Г.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epilepsia.su/jour/article/view/6
.
ReferencesКалинин В.В., Железнова Е.В. Противосудорожные и психотропные свойства антиэпилептических препаратов при лечении больных эпилепсией. М. 2008.Калинин В.В., Железнова Е.В. Противосудорожные и психотропные свойства антиэпилептических препаратов при лечении больных эпилепсией. М. 2008.Полянский Д.А. Клинико-терапевтические факторы риска суицидального поведения у больных эпилепсией. Автореферат канд. мед. наук. М. 2003; 30.Полянский Д.А. Клинико-терапевтические факторы риска суицидального поведения у больных эпилепсией. Автореферат канд. мед. наук. М. 2003; 30.Borges Gonçalves E., Cendes F. Depression in patients with refractory temporal lobe epilepsy. Arq Neuropsiquiatr. 2011; 69 (5): 775-777.Borges Gonçalves E., Cendes F. Depression in patients with refractory temporal lobe epilepsy. Arq Neuropsiquiatr. 2011; 69 (5): 775-777.Eddy M., Hugh E. Rickards, Andrea E. The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord. 2011; 4 (6): 385-407.Eddy M., Hugh E. Rickards, Andrea E. The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord. 2011; 4 (6): 385-407.Elger C. et al. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia. 2009; 50 (3): 454-463.Elger C. et al. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia. 2009; 50 (3): 454-463.Hufnagel A., Ben-Menachem E., Gabbai A.A. et al. Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year openlabel extension study. Epilepsy Res. 2013; 103: 262-269.Hufnagel A., Ben-Menachem E., Gabbai A.A. et al. Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year openlabel extension study. Epilepsy Res. 2013; 103: 262-269.Kanner A.M. Depression and Epilepsy: A New Perspective on Two Closely Related Disorders. Epilepsy Currents. September/October 2006; 6 (5): 141-146.Kanner A.M. Depression and Epilepsy: A New Perspective on Two Closely Related Disorders. Epilepsy Currents. September/October 2006; 6 (5): 141-146.Lambert M.V., Robertson M.M. Depression in Epilepsy: Etiology, Phenomenology and Treatment. Epilepsia. 1999; 40 (10): 21-47.Lambert M.V., Robertson M.M. Depression in Epilepsy: Etiology, Phenomenology and Treatment. Epilepsia. 1999; 40 (10): 21-47.Milovan D. et al. Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. Epilepsy & Behavior. 2010; 18: 366-373.Milovan D. et al. Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. Epilepsy & Behavior. 2010; 18: 366-373.Nashef L., Mohanraj R. et al. Eslicarbazepine acetate: who needs it? A Progress in Neurology and Psychiatry Supplement. January 2013.Nashef L., Mohanraj R. et al. Eslicarbazepine acetate: who needs it? A Progress in Neurology and Psychiatry Supplement. January 2013.Shorvon S.D., Reynolds E.H. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981; 22: 1-10.Shorvon S.D., Reynolds E.H. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981; 22: 1-10.
The authors declare that there are no conflicts of interest present.